Evidence map›Paper›PMID 34641142›Full record

ArticlePolymers2021

Preparation and Characterization of Aminoglycoside-Loaded Chitosan/Tripolyphosphate/Alginate Microspheres against

Estefanía Tiburcio, Eduardo García-Junceda, Leoncio Garrido, Alfonso Fernández-Mayoralas, Julia Revuelta, Agatha Bastida

Abstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Advances in Nanostructures for Antimicrobial Therapy.Materials (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Estefanía TiburcioBioGlycoChem Group, Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0001-5364-6532
Eduardo García-JuncedaBioGlycoChem Group, Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-2344-8743
Leoncio GarridoNanohybrids and Interactive Polymers Group, Institute of Polymer Science and Technology (ICTP-CSIC), CSIC, Juan de la Cierva 3, 28006 Madrid, Spain.
Alfonso Fernández-MayoralasBioGlycoChem Group, Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-1241-7538
Julia RevueltaBioGlycoChem Group, Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0001-6225-7336
Agatha BastidaBioGlycoChem Group, Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-5141-9595

Funding

Government of Spain PID2019-105337RB-C21
6 · The paper itself

Abstract

Although aminoglycosides are one of the common classes of antibiotics that have been widely used for treating infections caused by pathogenic bacteria, the evolution of bacterial resistance mechanisms and their inherent toxicity have diminished their applicability. Biocompatible carrier systems can help sustain and control the delivery of antibacterial compounds while reducing the chances of antibacterial resistance or accumulation in unwanted tissues. In this study, novel chitosan gel beads were synthesized by a double ionic co-crosslinking mechanism. Tripolyphosphate and alginate, a polysaccharide obtained from marine brown algae, were employed as ionic cross-linkers to prepare the chitosan-based networks of gel beads. The in vitro release of streptomycin and kanamycin A was bimodal; an initial burst release was observed followed by a diffusion mediated sustained release, based on a Fickian diffusion mechanism. Finally, in terms of antibacterial properties, the particles resulted in growth inhibition of Gram-negative (

Indexed as

antibiotic activityantibiotic deliverychitosan particlespolysaccharide carriersrelease kinetics

Identifiers

PMID34641142
PMCPMC8512199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.